Results 21 to 30 of about 121,878 (259)

Review of Noninvasive or Minimally Invasive Deep Brain Stimulation

open access: yesFrontiers in Behavioral Neuroscience, 2022
Brain stimulation is a critical technique in neuroscience research and clinical application. Traditional transcranial brain stimulation techniques, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and deep ...
Xiaodong Liu   +3 more
doaj   +1 more source

Functional imaging of deep brain stimulation in dystonia: a review

open access: yesDystonia, 2023
Much remains to be learned about the mechanism of benefit of deep brain stimulation in movement disorders in general and dystonia specifically. A full accounting of the pathophysiology of dystonia additionally remains unclear.
Ian O. Bledsoe, Melanie A. Morrison
doaj   +1 more source

Adaptive Deep Brain Stimulation for sleep stage targeting in Parkinson’s disease

open access: yesBrain Stimulation, 2023
Background: Sleep dysfunction is disabling in people with Parkinson’s disease and is linked to worse motor and non-motor outcomes. Sleep-specific adaptive Deep Brain Stimulation has the potential to target pathophysiologies of sleep.
Clay Smyth   +5 more
doaj   +1 more source

Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome

open access: yesFrontiers in Psychiatry
IntroductionIrritable bowel syndrome (IBS) is a common condition characterized by abdominal pain and altered bowel habits, affecting around 11% of individuals globally.
Mohamed A. Abdelnaim   +9 more
doaj   +1 more source

Deep brain stimulation of the nucleus accumbens core but not shell reduces motivational components of heroin taking and seeking in rats

open access: yesBrain and Neuroscience Advances, 2017
Background: Deep brain stimulation is explored as a new intervention for treatment-resistant substance use dependence. A candidate brain region is the nucleus accumbens, due to its involvement in reward and motivation. This study aimed to explore effects
Maria C. Schippers   +7 more
doaj   +1 more source

The quest for a target and the beginning of the DBS-story

open access: yesDeep Brain Stimulation
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has revolutionized the treatment of Parkinson’s disease. It is considered as a treatment of choice, after Levodopa, for patients suffering from advanced stages of the disease.
Abdelhamid Benazzouz
doaj   +1 more source

The Oscillatory Profile Induced by the Anxiogenic Drug FG-7142 in the Amygdala–Hippocampal Network Is Reversed by Infralimbic Deep Brain Stimulation: Relevance for Mood Disorders

open access: yesBiomedicines, 2021
Anxiety and depression exhibit high comorbidity and share the alteration of the amygdala–hippocampal–prefrontal network, playing different roles in the ventral and dorsal hippocampi.
Hanna Vila-Merkle   +8 more
doaj   +1 more source

Neurophysiology in deep brain stimulation: Bridging clinical practice and systems neuroscience

open access: yesDeep Brain Stimulation
As understanding of neurophysiology has progressed from individual neurons to large-scale brain networks, deep brain stimulation (DBS) has been established as a major intervention for neurological and psychiatric diseases. Here we review (1) the clinical
Julie Lewentz   +2 more
doaj   +1 more source

Targeting pain with deep brain stimulation: Insights into the thalamus and associated structures

open access: yesDeep Brain Stimulation
Chronic pain is a major public health issue, and despite advances in understanding its pathophysiology, current treatments remain insufficient, significantly affecting patients' quality of life.
Rabia Bouali-Benazzouz   +2 more
doaj   +1 more source

Deep Brain Stimulation for Depression

open access: yesNeurotherapeutics, 2022
Deep brain stimulation has been extensively studied as a therapeutic option for treatment-resistant depression (TRD). DBS across different targets is associated with on average 60% response rates in previously refractory chronically depressed patients. However, response rates vary greatly between patients and between studies and often require extensive
Martijn Figee   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy